Immunosuppressive drug use during pregnancy

R. Ramsey-Goldman*, E. Schilling

*Corresponding author for this work

Research output: Contribution to journalArticle

97 Scopus citations

Abstract

Women with rheumatic diseases frequently need treatment throughout pregnancy and lactation. It is essential that the maternal disease be well controlled prior to, during, and after pregnancy to ensure the best possible outcome for the mother and child. Corticosteroids have been used extensively and safely in patients with rheumatic disease during pregnancy and lactation. There is considerable experience using azathioprine during pregnancy if the maternal condition requires use of a cytotoxic drug; there has been no increased risk of congenital malformations in the exposed infants. There is limited information on the safety of other medications, including 6-mercaptopurine, cyclophosphamide, and cyclosporine. Methotrexate and chlorambucil are contraindicated during pregnancy. Immunosuppressive medications such as, azathioprine, 6-mercaptopurine, chlorambucil, cyclophosphamide, cyclosporine, and methotrexate are contraindicated during lactation.

Original languageEnglish (US)
Pages (from-to)149-167
Number of pages19
JournalRheumatic Disease Clinics of North America
Volume23
Issue number1
DOIs
StatePublished - Jan 1 1997

ASJC Scopus subject areas

  • Rheumatology

Fingerprint Dive into the research topics of 'Immunosuppressive drug use during pregnancy'. Together they form a unique fingerprint.

  • Cite this